KROS Competitors & Alternatives
Compare Keros Therapeutics Inc with similar stocks in the same industry
Biotechnology
KROS
Main Stock$11.10
Tradestie Score
58
Market Cap
$620.60M
Revenue Growth
-1.0%
Analyst Upside
+96.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$10.01
|
$281.75M | 9.0 | 58 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.98
|
$275.54M | - | 57 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.93
|
$275.13M | - | 44 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.03
|
$269.08M | - | 59 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$7.77
|
$258.18M | - | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$38.32
|
$256.54M | - | 62 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$12.62
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.50
|
$202.58M | - | 63 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.96
|
$188.81M | 342.5 | 55 | Compare |
More KROS Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry